Publicaciones en colaboración con investigadores/as de Hospital Universitari de Girona Dr. Josep Trueta (131)

2024

  1. Consensus statement of the Spanish Society of Neurology on the treatment of multiple sclerosis and holistic patient management in 2023

    Neurologia, Vol. 39, Núm. 2, pp. 196-208

  2. Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: results of the BURKIMAB14 trial

    Haematologica, Vol. 109, Núm. 2, pp. 543-552

  3. Long-term survival after cardiac arrest in patients undergoing emergent coronary angiography

    Cardiovascular Revascularization Medicine, Vol. 60, pp. 18-26

  4. Vaccine–carditis study: Spanish multicenter registry of inflammatory heart disease after COVID-19 vaccination

    Clinical Research in Cardiology, Vol. 113, Núm. 2, pp. 223-234

2023

  1. Association of Serum Neurofilament Light Chain Levels at Disease Onset with Disability Worsening in Patients with a First Demyelinating Multiple Sclerosis Event Not Treated with High-Efficacy Drugs

    JAMA Neurology, Vol. 80, Núm. 4, pp. 397-403

  2. Association of Time of Day with Outcomes among Patients Triaged for a Suspected Severe Stroke in Nonurban Catalonia

    Stroke, Vol. 54, Núm. 3, pp. 770-780

  3. Cost analysis of a patient blood management program for patients undergoing gastric cancer surgery

    European Journal of Surgical Oncology, Vol. 49, Núm. 1, pp. 293-297

  4. Effect of Perioperative Blood Transfusions and Infectious Complications on Inflammatory Activation and Long-Term Survival Following Gastric Cancer Resection

    Cancers, Vol. 15, Núm. 1

  5. Epidemiology of ataxia and hereditary spastic paraplegia in Spain: a cross-sectional study

    Neurologia, Vol. 38, Núm. 6, pp. 379-386

  6. Estimating the Prevalence of Cardiac Amyloidosis in Old Patients with Heart Failure—Barriers and Opportunities for Improvement: The PREVAMIC Study

    Journal of Clinical Medicine, Vol. 12, Núm. 6

  7. Evolution of quality indicators in acute stroke during the RACECAT Trial: Impact in the general population

    International Journal of Stroke, Vol. 18, Núm. 2, pp. 229-236

  8. First pass effect in posterior circulation occlusions: Analysis from the CICAT registry

    International Journal of Stroke, Vol. 18, Núm. 2, pp. 221-228

  9. Influence of vascular imaging acquisition at local stroke centers on workflows in the drip-n-ship model: A RACECAT post hoc analysis

    Journal of NeuroInterventional Surgery, Vol. 16, Núm. 2, pp. 143-150

  10. Parenteral Nutrition: Current Use, Complications, and Nutrition Delivery in Critically Ill Patients

    Nutrients, Vol. 15, Núm. 21

  11. Plasma acylcarnitines and gut-derived aromatic amino acids as sex-specific hub metabolites of the human aging metabolome

    Aging Cell, Vol. 22, Núm. 6

  12. Reperfusion treatment in acute ischaemic stroke due to cervical and cerebral artery dissection: results of a Spanish national multicentre study

    Neurologia, Vol. 38, Núm. 6, pp. 412-418

  13. Seroprevalence of SARS-CoV-2 in Patients with Multiple Sclerosis under Disease-Modifying Therapies: A Multi-Centre Study

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  14. Sex and gender differences in acute stroke care: metrics, access to treatment and outcome. A territorial analysis of the Stroke Code System of Catalonia

    European Stroke Journal, Vol. 8, Núm. 2, pp. 557-565

  15. Vitamin D and Chronic Kidney Disease Association with Mineral and Bone Disorder: An Appraisal of Tangled Guidelines

    Nutrients, Vol. 15, Núm. 7

  16. XV Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2022 (I)

    Revista de neurologia, Vol. 77, Núm. 1, pp. 19-30